Holland et al. used complementary DNA (cDNA) microarrays in order to explore the transcriptome of endometrial carcinoma tissues and suggested elevated PPARα and PPARγ levels in endometrial cancer. This evidence concerns the gene PPARA and endometrial carcinoma.